These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 23441359

  • 1. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome.
    Koşan C, Ayar G, Orbak Z.
    West Indian Med J; 2012 Sep; 61(6):627-30. PubMed ID: 23441359
    [Abstract] [Full Text] [Related]

  • 2. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [Abstract] [Full Text] [Related]

  • 3. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Przegl Lek; 2007 Mar; 64(9):552-8. PubMed ID: 18510075
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of bone mineral turnover in children with nephrotic syndrome--the implications of original disease and the effects of corticosteroids on bone metabolism].
    Takeda Y.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):705-13. PubMed ID: 8377283
    [Abstract] [Full Text] [Related]

  • 5. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Jun; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 6. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S.
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [Abstract] [Full Text] [Related]

  • 7. The effect of the steroid-sparing response to low-dose methotrexate on bone metabolism in glucocorticoid-dependent asthmatics.
    Girgis SI, Nwokeji A, Shakur BH, Ind PW, Shiner RJ.
    Clin Chim Acta; 2004 Mar; 341(1-2):157-63. PubMed ID: 14967172
    [Abstract] [Full Text] [Related]

  • 8. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
    Terzi T, Terzi M, Tander B, Cantürk F, Onar M.
    J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
    [Abstract] [Full Text] [Related]

  • 9. Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome.
    Mohamed GB, Abdel-Latif EA.
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):955-62. PubMed ID: 21912025
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
    Bak M, Serdaroglu E, Guclu R.
    Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
    [Abstract] [Full Text] [Related]

  • 12. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [Abstract] [Full Text] [Related]

  • 13. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP.
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [Abstract] [Full Text] [Related]

  • 14. Bone density and metabolism in subjects with microdeletion of chromosome 22q11 (del22q11).
    Stagi S, Lapi E, Gambineri E, Manoni C, Genuardi M, Colarusso G, Conti C, Chiarelli F, de Martino M, Azzari C.
    Eur J Endocrinol; 2010 Aug; 163(2):329-37. PubMed ID: 20516202
    [Abstract] [Full Text] [Related]

  • 15. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.
    Duzen O, Erkoc R, Begenik H, Soyoral YU, Aldemir MN.
    Ren Fail; 2012 Aug; 34(3):338-42. PubMed ID: 22260330
    [Abstract] [Full Text] [Related]

  • 16. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 17. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.
    Pennisi P, D'Alcamo MA, Leonetti C, Clementi A, Cutuli VM, Riccobene S, Parisi N, Fiore CE.
    J Bone Miner Metab; 2005 Sep; 23(2):134-9. PubMed ID: 15750691
    [Abstract] [Full Text] [Related]

  • 18. Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy.
    Siomou E, Challa A, Tzoufi M, Papadopoulou ZL, Lapatsanis PD, Siamopoulou A.
    Calcif Tissue Int; 2003 Oct; 73(4):319-25. PubMed ID: 12874699
    [Abstract] [Full Text] [Related]

  • 19. Fractional calcium absorption is increased in girls with Rett syndrome.
    Motil KJ, Schultz RJ, Abrams S, Ellis KJ, Glaze DG.
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
    [Abstract] [Full Text] [Related]

  • 20. Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome.
    Sierra RI, Specker BL, Jiménez F, Cruz C, Pedraza-Chaverrí J.
    Ren Fail; 1997 May; 19(3):409-24. PubMed ID: 9154658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.